![Geofrey de Visscher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Geofrey de Visscher
Corporate Officer/Principal chez Katholieke Universiteit Leuven
Profil
Geofrey de Visscher is the founder of Anethon NV, which was founded in 2011.
He held the title of Inventor from 2011 to 2013.
Dr. de Visscher's current job is as a Principal at Katholieke Universiteit Leuven, which he started in 2001.
Dr. de Visscher's former job was as a Manager-Research & Innovation at the University of Antwerp, which he held from 2009 to 2011.
Dr. de Visscher received a doctorate degree from Maastricht University in 2001 and a graduate degree from Vrije Universiteit Brussel in 1997.
Postes actifs de Geofrey de Visscher
Sociétés | Poste | Début |
---|---|---|
Katholieke Universiteit Leuven | Corporate Officer/Principal | 01/01/2001 |
Anciens postes connus de Geofrey de Visscher
Sociétés | Poste | Fin |
---|---|---|
Anethon NV
![]() Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Fondateur | 07/08/2013 |
University of Antwerp | Corporate Officer/Principal | 01/10/2011 |
Formation de Geofrey de Visscher
Vrije Universiteit Brussel | Graduate Degree |
Maastricht University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Anethon NV
![]() Anethon NV Pharmaceuticals: MajorHealth Technology Anethon is a medical device company developing second generation biomimetic cardiovascular prostheses. These devices are class III implants encompassing blood vessels, patches and heart valves. The company, a Flanders based spin-off of the KULeuven, was incorporated in July 2011, to exploit IP and know-how generated by its founders, Prof Willem Flameng, a key opinion leader in cardiac surgery, and Geofrey De Visscher, PhD. | Health Technology |